Ofer Haviv is the CEO and President of Evogene, a computational biology company specializing in transforming product discovery and development across various life science industries, including human health and agriculture.
Evogene’s core technology is its versatile Computational Predictive Biology (CPB) platform, which uses unique technological engines that integrate data, computational systems, and a deep understanding of life sciences to drive innovation across different fields.
Evogene’s long-term goals are to invest in their technology engines, expand the variety of their engine’s usage and promote the value of their subsidiaries.
The core principle behind Evogene's CPB platform with its AI tech-engines is that it integrates a deep understanding of biology and chemistry with AI, machine learning, computational models, and biological data to perform analyses across millions of data points.
Evogene attracts top-tier talent in biology, AI, and data science by fostering a collaborative environment that integrates multidisciplinary experience and creativity in their team to tackle complex challenges with innovative solutions.
Evogene's collaboration with Google Cloud is a partnership that has driven advanced AI technologies to transform small molecule drug discovery and development.
The foundation model is a cutting-edge innovation in drug and product development, enabling pre-training on significantly larger datasets than traditional AI-methods which also allows for getting deeper insights.
Evogene’s competitive edge stems from the expertise of its multidisciplinary team, agility in tailoring solutions to market needs, and proprietary algorithms to enhance screening and optimization.
Evogene envisions expanding their technological reach through strategic partnerships to shape the future of life sciences product development.